Clinical Trial Update: The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating tafamidis for transthyretin amyloidosis, focusing on stabilization, safety, tolerability, and efficacy in transthyret…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Polyneuropathy
• Transthyretin Amyloidosis

Drugs mentioned

• Tafamidis (tafamidis)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Transthyretin Amyloidosis | Phase 4 | Status: UNKNOWN